chevron_leftBack
As of 20 June 2026, Syschem (India) Ltd. has a market cap of $26.89M USD, ranking #35006 globally and #2404 in India.
It ranks #3162 in the Healthcare sector, and #1069 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$26.89MUSD
2.54B INR
Enterprise Value
$26.41MUSD
2.49B INR
Revenue (TTM)
$57.75MUSD
5.45B INR
EBITDA (TTM)
$1.42MUSD
134.47M INR
Net Income (TTM)
$869.11KUSD
82.03M INR
EBITDA Margin
2.5%
Profit Margin
1.5%
PE Ratio
35.2
PS Ratio
0.5
PB Ratio
2.7
EV/EBITDA
18.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ranjan Jain
open_in_new
Employees
115
Founded
1993
Website
syschem.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.6% | 1.1% | 18% | 10% | -6.7% | 28% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
531173
(SYSCHEM)
Syschem (India) Ltd
ISIN: INE121D01036
Shares Out.:
Shares Outstanding:
49.013M1
Shares Float:
39.183M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
51.78 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Syschem (India) Ltd.
Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
168K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
68K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
56K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
44K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
37K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
36K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
3M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$318.3B
1M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
1M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
1M%
|
15.1
|
chevron_leftBack